Jaguar Health (JAGX) Preferred Shares (2018 - 2025)

Jaguar Health's (JAGX) quarterly Preferred Shares came in at $2.5 million in Q4 2025, little changed on a QoQ basis from $2.5 million in Q3 2025.

Jaguar Health (JAGX) Preferred Shares (2018 - 2025) Analysis & Trends

Jaguar Health (JAGX) has 4 years of Preferred Shares data on file, last reported at $2.5 million in Q4 2025.

On a quarterly basis, Preferred Shares changed N/A year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $2.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.5 million, changed N/A from the prior year.
Preferred Shares for Q4 2025 stood at $2.5 million, roughly flat from $2.5 million in the prior quarter.
Over the last five years, Preferred Shares for JAGX reached as high as $2.5 million in Q2 2025 and fell as low as $2.5 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Nanobiotix	1,774.59 Bn	1,774.53 Bn	-	-
2	Akari Therapeutics	1,009.43 Bn	1,009.43 Bn	-	-
3	BeOne Medicines	473.53 Bn	468.74 Bn	1.35 Bn	-
4	Vertex Pharmaceuticals	123.91 Bn	116.66 Bn	2.59 Bn	-
5	Regeneron Pharmaceuticals	71.79 Bn	63.04 Bn	3.31 Bn	-
6	Belite Bio	62.15 Bn	62.15 Bn	-	-
7	Argenx Se	54.75 Bn	49.57 Bn	1.41 Bn	-
8	Alnylam Pharmaceuticals	38.10 Bn	35.10 Bn	959.66 Mn	-
9	Revolution Medicines	36.11 Bn	36.11 Bn	-	-
10	Jaguar Health	509,443.80	-9.55 Mn	19.11 Mn	-

Download Data